pharma-company /Medicinal products /Active ingredients

Rx · PZN 16528275

EPCLUSA 200 mg/50 mg film-coated tablets Paed.

German trade nameEPCLUSA 200 mg-50 mg Filmtabletten pädiatrisch

Active ingredientSofosbuvir and velpatasvirSubstance (DE)Sofosbuvir und VelpatasvirPharmaceutical formFilm-coated tablets

Available with fluctuations

3.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €8,110

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for EPCLUSA 200 mg/50 mg film-coated tablets Paed..

Review purchasing terms

EPCLUSA 200 mg/50 mg film-coated tablets Paed. contains the active ingredient Sofosbuvir and velpatasvir (German Sofosbuvir und Velpatasvir) and comes as Film-coated tablets. One pack size is recorded (PZN 16528275). The pharma availability index for German wholesale stands at 3.5 out of 10 over the past 30 days – the pack was therefore available with fluctuations.

Availability of EPCLUSA 200 mg/50 mg film-coated tablets Paed. fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

More products containing Sofosbuvir and velpatasvir

EPCLUSA 400 mg/100 mg film-coated tablets9.6EPCLUSA 150 mg/37,5 mg befilmt. granules in sachet Paed0.0EPCLUSA 200 mg/50 mg befilmt. granules in sachet Paed.0.0
Active ingredient overview: Sofosbuvir and velpatasvir →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.